In September, 2015, the UK became the first country to implement a broad-spectrum, recombinant protein-based meningococcal B vaccine (4CMenB, Bexsero, GSK Biologicals, Sovicille-Siena, Italy) programme into its national infa...
In Europe, only recently some countries, including Spain, Finland, Latvia and the United Kingdom have initiated immunisation programs for healthy infants and young children [7,8]. In Greece, influenza vaccination is recommended for children over 6 months with chronic medical conditions (e.g., ...